Martina Reitz

1.7k total citations
41 papers, 1.2k citations indexed

About

Martina Reitz is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Martina Reitz has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Martina Reitz's work include Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Martina Reitz is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Martina Reitz collaborates with scholars based in Germany, United Kingdom and France. Martina Reitz's co-authors include Jens Atzpodien, T Wandert, Patrick Royston, Minka Breloer, H. Heynemann, Paolo Fornara, Bernd Metzner, Hartmut Kirchner, Wiebke Hartmann and Harold C. Schott and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Martina Reitz

39 papers receiving 1.2k citations

Peers

Martina Reitz
Shujuan Jiang China
Hans‐Jürgen Gruss Germany
Fraia Melchionda Italy
William M. Lin United States
Beena Kumar Australia
Victoria Marcus Canada
Florian Cabillic France
Ligia Craciun Belgium
Naoki Ikeda Japan
Shujuan Jiang China
Martina Reitz
Citations per year, relative to Martina Reitz Martina Reitz (= 1×) peers Shujuan Jiang

Countries citing papers authored by Martina Reitz

Since Specialization
Citations

This map shows the geographic impact of Martina Reitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Reitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Reitz more than expected).

Fields of papers citing papers by Martina Reitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Reitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Reitz. The network helps show where Martina Reitz may publish in the future.

Co-authorship network of co-authors of Martina Reitz

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Reitz. A scholar is included among the top collaborators of Martina Reitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Reitz. Martina Reitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reitz, Martina, et al.. (2020). Limited role of mast cells during infection with the parasitic nematode Litomosoides sigmodontis. PLoS neglected tropical diseases. 14(7). e0008534–e0008534. 7 indexed citations
2.
Reitz, Martina, et al.. (2020). IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation. PLoS Pathogens. 16(12). e1009121–e1009121. 35 indexed citations
3.
Reitz, Martina, Thorsten B. Feyerabend, Axel Roers, et al.. (2016). Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection. Mucosal Immunology. 10(2). 481–492. 40 indexed citations
4.
Blankenhaus, Birte, Martina Reitz, Wiebke Hartmann, et al.. (2014). Foxp3+ Regulatory T Cells Delay Expulsion of Intestinal Nematodes by Suppression of IL-9-Driven Mast Cell Activation in BALB/c but Not in C57BL/6 Mice. PLoS Pathogens. 10(2). e1003913–e1003913. 45 indexed citations
5.
Brunner, Georg, Martina Reitz, Achim Heinecke, et al.. (2012). A nine-gene signature predicting clinical outcome in cutaneous melanoma. Journal of Cancer Research and Clinical Oncology. 139(2). 249–258. 52 indexed citations
6.
Brunner, Georg, Martina Reitz, V. Schwipper, et al.. (2008). Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients. Cancer Biotherapy and Radiopharmaceuticals. 23(4). 451–460. 30 indexed citations
7.
Atzpodien, Jens & Martina Reitz. (2008). Peripheral Blood Neutrophils as Independent Immunologic Predictor of Response and Long-Term Survival upon Immunotherapy in Metastatic Renal-Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 23(1). 129–134. 33 indexed citations
8.
Atzpodien, Jens & Martina Reitz. (2007). GM-CSF Plus Antigenic Peptide Vaccination in Locally Advanced Melanoma Patients. Cancer Biotherapy and Radiopharmaceuticals. 22(4). 551–555. 7 indexed citations
9.
Atzpodien, Jens, et al.. (2007). Fractional Polynomials in a New Metastatic Renal Carcinoma Continuous Prognostic Index Involving Histology, Laboratory, and Clinical Predictors. Cancer Biotherapy and Radiopharmaceuticals. 22(6). 812–818. 2 indexed citations
10.
Atzpodien, Jens, et al.. (2007). Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients. Cancer Chemotherapy and Pharmacology. 62(4). 685–688. 12 indexed citations
11.
Atzpodien, Jens & Martina Reitz. (2006). Long-Term Maintenance Therapy in Interferon-α2a/Interleukin-2-Pretreated Advanced Renal-Cell Carcinoma Patients. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 206–210. 3 indexed citations
12.
Atzpodien, Jens & Martina Reitz. (2005). Metastatic Renal Carcinoma Long-Term Survivors Treated with s.c. Interferon-Alpha and s.c. Interleukin-2. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 410–416. 8 indexed citations
13.
Fluck, Michael, Darab Kamanabrou, Andrea Lippold, Martina Reitz, & Jens Atzpodien. (2005). Dose-Dependent Treatment Benefit in High-Risk Melanoma Patients Receiving Adjuvant High-Dose Interferon Alfa-2b. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 280–289. 2 indexed citations
14.
Atzpodien, Jens, T Wandert, & Martina Reitz. (2005). Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma. Critical Reviews in Oncology/Hematology. 55(3). 193–199. 13 indexed citations
15.
Dallmann, Iris, et al.. (2004). Predictive Impact of Retinoid X Receptor-Alpha-Expression in Renal-Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 331–342. 18 indexed citations
16.
Atzpodien, Jens, Michael Fluck, & Martina Reitz. (2004). Individualized Synthetic Peptide Vaccines with GM-CSF in Locally Advanced Melanoma Patients. Cancer Biotherapy and Radiopharmaceuticals. 19(6). 758–763. 8 indexed citations
17.
18.
Duensing, Anette, et al.. (2002). Interleukin-12 Inhibits Apoptosis in Chronic Lymphatic Leukemia (CLL) B Cells. Cancer Biotherapy and Radiopharmaceuticals. 17(5). 495–499. 6 indexed citations
19.
20.
Atzpodien, Jens, Hartmut Kirchner, Bernd Metzner, et al.. (2001). IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. British Journal of Cancer. 85(8). 1130–1136. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujuan Jiang Breakdown of academic impact, for papers by Hans‐Jürgen Gruss Breakdown of academic impact, for papers by Fraia Melchionda Breakdown of academic impact, for papers by William M. Lin Breakdown of academic impact, for papers by Beena Kumar Breakdown of academic impact, for papers by Victoria Marcus Breakdown of academic impact, for papers by Florian Cabillic Breakdown of academic impact, for papers by Ligia Craciun Breakdown of academic impact, for papers by Naoki Ikeda
Rankless by CCL
2026